DIA Biosimilars 2013

Europe

Vetter receives Frost & Sullivan award

Friday, July 15, 2011 10:50 AM

Vetter has received the Frost & Sullivan 2011 European Prefilled Injection Systems Customer Service Leadership Award. The international consulting company recognized Vetter for best practices in its collaboration with global customers; in particular, the quality of service the company creates for its partners. Vetter provides support from early development of drugs through regulatory approval and market supply worldwide.

More... »

Cenduit: Now with Patient Reminders

Frances unveils drug regulation overhaul

Friday, July 15, 2011 10:10 AM

Health minister Xavier Bertrand says new regulation will strengthen pharmacovigilance, create greater transparency and more declaration of interests at all levels of regulation and government, according to InPharm.

More... »

CRF Health – eCOA Forum

ICON acquires Firecrest Clinical to enhance site performance

Thursday, July 14, 2011 01:03 PM

Dublin, Ireland-based global CRO Icon has agreed to acquire Firecrest Clinical, a provider of technology solutions that boost investigator site performance and study management.

More... »

EMA releases paper on biomarker use for comment

Thursday, July 14, 2011 12:43 PM

The European Medicines Agency (EMA) has put out for consultation a reflection paper on the use of pharmacogenomic biomarkers as patient selection and treatment stratification tools in drug development, according to PharmaTimes.

More... »

Triple alliance forged to create end-to-end therapeutic discovery platform

Wednesday, June 29, 2011 12:14 PM

Three U.K.-based biotech companies, Isogenica, Biolauncher and Cresset Biomolecular Discovery, have formed a collaborative joint venture, according to the U.K.’s Business Weekly.

More... »

Five European CROs merge to form NEOX Europe

Friday, June 24, 2011 10:40 AM

Five independent CROs with operations stretching from Eastern to Western Europe have grouped together to form a new entity that will “act as one team and one company,” according to a report from PharmaTimes.

More... »

Pfizer puts Sandwich R&D site on market

Tuesday, June 14, 2011 02:28 PM

Pfizer's giant research base at Sandwich, southern England, has been officially put on the market by CB Richard Ellis, according to Reuters. U.S.-based Pfizer in February decided to close the site.

More... »

Roche partners for translational research

Tuesday, June 7, 2011 03:24 PM

The University of Geneva (UNIGE), Geneva University Hospitals (HUG) and the Swiss Institute of Bioinformatics (SIB) have formed a strategic collaboration with Roche in translational medical research. The initial focus will be on basic research, bioinformatics and biomarker development in cardiology, hematology, pathology and applied human toxicology.

More... »

Drug discovery industry in midst of 'profound change'

Thursday, June 2, 2011 12:50 PM

Drug makers are "defining a new contract with society" as they overhaul their R&D, according to the former head of the sector's trade body.

More... »

Pfizer still seeking CROs for U.K. site

Thursday, June 2, 2011 11:21 AM

Pfizer continues to search for CROs to occupy a U.K. site, but the local council is disappointed by the lack of government action.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs